A prospective, randomized, two-arm, single-blind, parallel, active-controlled, multicentre, non-inferiority, phase II/III clinical study to evaluate the immunogenicity and safety of Diphtheria, Tetanus and Pertussis (Whole Cell) Vaccine (Adsorbed) of M/s Cadila Healthcare Limited compared to Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) of M/s Serum Institute of India Limited in healthy infants
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Diphtheria tetanus and pertussis vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Cadila Healthcare
- 21 Aug 2017 Status changed from active, no longer recruiting to completed.
- 01 Sep 2016 New trial record